Side-by-side financials for CADL and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CADL | ARGX |
|---|---|---|
| Market cap | - | $55.63 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $125.00K | - |
| Net income (latest FY) | -$38.18M | - |
| Net margin | -30545.6% | - |
| SEC filings | 382 | 272 |
Full pages: Candel Therapeutics, Inc. and ARGENX SE, or browse the full rankings.